US 12,213,946 B2
Dosing control coupling for enteral fluid transfer
Benjamin M. Davis, Woodstock, GA (US); Aaron N. Ingram, Canton, GA (US); Duane Webb, Roswell, GA (US); and Mariann Cary, Canton, GA (US)
Assigned to Avent, Inc., Alpharetta, GA (US)
Filed by Avent, Inc., Alpharetta, GA (US)
Filed on Aug. 8, 2019, as Appl. No. 16/535,924.
Application 16/535,924 is a continuation of application No. 15/210,282, filed on Jul. 14, 2016, granted, now 10,420,709.
Claims priority of provisional application 62/350,934, filed on Jun. 16, 2016.
Claims priority of provisional application 62/207,120, filed on Aug. 19, 2015.
Claims priority of provisional application 62/192,454, filed on Jul. 14, 2015.
Prior Publication US 2020/0030190 A1, Jan. 30, 2020
Int. Cl. A61J 15/00 (2006.01); A61J 7/00 (2006.01); A61M 5/31 (2006.01); A61M 5/34 (2006.01); A61M 39/10 (2006.01); A61M 39/12 (2006.01)
CPC A61J 15/0026 (2013.01) [A61J 7/0053 (2013.01); A61M 5/3134 (2013.01); A61M 5/345 (2013.01); A61M 39/1011 (2013.01); A61M 39/12 (2013.01); A61M 2039/1077 (2013.01); A61M 2039/1094 (2013.01)] 24 Claims
OG exemplary drawing
 
1. An enteral dosing control coupling comprising:
a cylindrical collar defining
a hollow internal chamber,
a smooth interior surface,
a collar axial length, and
a collar free end; and
a lumen extension tip projecting axially into the hollow internal chamber and defining an internal lumen extending axially through the lumen extension tip,
a tip axial length that is shorter than the collar axial length,
a tip free end recessed below the collar free end, and
a contained volume of 0.005 milliliters to about 0.03 milliliters.